Park, Kyung Woo <br/><br/>
Everolimus-eluting Xience v/Promus versus zotarolimus-eluting resolute stents in patients with diabetes mellitus.  [electronic resource] 

 -  JACC. Cardiovascular interventions  May 2014 
 - 471-81 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Observational Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1876-7605 
<br/><br/><label>Standard No.: </label>10.1016/j.jcin.2013.12.201  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Cardiovascular Agents--administration & dosage<br/>Chi-Square Distribution<br/>Coronary Angiography<br/>Coronary Artery Disease--diagnosis<br/>Diabetes Mellitus, Type 1--complications<br/>Diabetes Mellitus, Type 2--complications<br/>Diabetic Angiopathies--diagnosis<br/>Drug-Eluting Stents<br/>Everolimus<br/>Female<br/>Humans<br/>Kaplan-Meier Estimate<br/>Kidney Failure, Chronic--complications<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Myocardial Infarction--etiology<br/>Patient Selection<br/>Percutaneous Coronary Intervention--adverse effects<br/>Propensity Score<br/>Proportional Hazards Models<br/>Prosthesis Design<br/>Registries<br/>Republic of Korea<br/>Risk Factors<br/>Sirolimus--administration & dosage<br/>Time Factors<br/>Treatment Outcome